Image

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Recruiting
All
Phase N/A

Powered by AI

Overview

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.

Description

CoRDS collects contact, sociodemographic and health information about participants. This information is entered into CoRDS and linked to a unique coded identifier. Below are some examples of information requested on the Questionnaire that will be entered into CoRDS:

  • Contact information: Name, Mailing Address, Phone Number, Email Address
  • Sociodemographic information: Date of Birth, Place of Birth, Sex, Gender, Ethnicity
  • Health information: Family History, Information related to Diagnosis

De-identified information in CoRDS will be made available to researchers, if they have obtained approval for their research project from (1) the Institutional Review Board (IRB) at the researcher's institution and (2) a panel of experts.

A subset of de-identified information collected from each profile may be shared with certain other databases. This is done in order to help improve understanding of rare diseases, to avoid the duplication of efforts and to collaborate with existing research efforts with organizations dedicated to rare diseases.

Participants may elect to have their information shared with patient advocacy groups (PAGs) representing individuals with rare or uncommon diseases who have partnered with CoRDS. The PAG will sign an agreement stating that they will not use the information for Research purposes. CoRDS personnel will not be held responsible for the use of information by the PAG.

The CoRDS Registry will not be paid by Researchers, Other Patient Registries or Patient Advocacy Groups (PAGs) for access to information in CoRDS.

If a parent/LAR consents on behalf of a minor, CoRDS will contact the participant when he or she reaches the age of 18 in order to obtain consent. If this consent is not obtained in a timely manner, the participant will be withdrawn from CoRDS.

CoRDS contacts participants annually to confirm continued interest in participation in CoRDS, and to request that participants update the information they have provided.

Eligibility

Inclusion Criteria:

  • Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an unaffected carrier of a rare/uncommon disease

Exclusion Criteria:

  • Diagnosis of a disease which is not rare

Study details
    Rare Disorders
    Undiagnosed Disorders
    Disorders of Unknown Prevalence
    Cornelia De Lange Syndrome
    Prenatal Benign Hypophosphatasia
    Perinatal Lethal Hypophosphatasia
    Odontohypophosphatasia
    Adult Hypophosphatasia
    Childhood-onset Hypophosphatasia
    Infantile Hypophosphatasia
    Hypophosphatasia
    Kabuki Syndrome
    Bohring-Opitz Syndrome
    Narcolepsy Without Cataplexy
    Narcolepsy-cataplexy
    Hypersomnolence Disorder
    Idiopathic Hypersomnia Without Long Sleep Time
    Idiopathic Hypersomnia With Long Sleep Time
    Idiopathic Hypersomnia
    Kleine-Levin Syndrome
    Kawasaki Disease
    Leiomyosarcoma
    Leiomyosarcoma of the Corpus Uteri
    Leiomyosarcoma of the Cervix Uteri
    Leiomyosarcoma of Small Intestine
    Acquired Myasthenia Gravis
    Addison Disease
    Hyperacusis (Hyperacousis)
    Juvenile Myasthenia Gravis
    Transient Neonatal Myasthenia Gravis
    Williams Syndrome
    Lyme Disease
    Myasthenia Gravis
    Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)
    Isolated Klippel-Feil Syndrome
    Frasier Syndrome
    Denys-Drash Syndrome
    Beckwith-Wiedemann Syndrome
    Emanuel Syndrome
    Isolated Aniridia
    Axenfeld-Rieger Syndrome
    Aniridia-intellectual Disability Syndrome
    Aniridia - Renal Agenesis - Psychomotor Retardation
    Aniridia - Ptosis - Intellectual Disability - Familial Obesity
    Aniridia - Cerebellar Ataxia - Intellectual Disability
    Aniridia - Absent Patella
    Aniridia
    Peters Anomaly - Cataract
    Peters Anomaly
    Potocki-Shaffer Syndrome
    Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11
    Silver-Russell Syndrome Due to Imprinting Defect of 11p15
    Silver-Russell Syndrome Due to 11p15 Microduplication
    Syndromic Aniridia
    WAGR Syndrome
    Wolf-Hirschhorn Syndrome
    4p16.3 Microduplication Syndrome
    4p Deletion Syndrome
    Non-Wolf-Hirschhorn Syndrome
    Autosomal Recessive Stickler Syndrome
    Stickler Syndrome Type 2
    Stickler Syndrome Type 1
    Stickler Syndrome
    Mucolipidosis Type 4
    X-linked Spinocerebellar Ataxia Type 4
    X-linked Spinocerebellar Ataxia Type 3
    X-linked Intellectual Disability - Ataxia - Apraxia
    X-linked Progressive Cerebellar Ataxia
    X-linked Non Progressive Cerebellar Ataxia
    X-linked Cerebellar Ataxia
    Vitamin B12 Deficiency Ataxia
    Toxic Exposure Ataxia
    Unclassified Autosomal Dominant Spinocerebellar Ataxia
    Thyroid Antibody Ataxia
    Sporadic Adult-onset Ataxia of Unknown Etiology
    Spinocerebellar Ataxia With Oculomotor Anomaly
    Spinocerebellar Ataxia With Epilepsy
    Spinocerebellar Ataxia With Axonal Neuropathy Type 2
    Spinocerebellar Ataxia Type 8
    Spinocerebellar Ataxia Type 7
    Spinocerebellar Ataxia Type 6
    Spinocerebellar Ataxia Type 5
    Spinocerebellar Ataxia Type 4
    Spinocerebellar Ataxia Type 37
    Spinocerebellar Ataxia Type 36
    Spinocerebellar Ataxia Type 35
    Spinocerebellar Ataxia Type 34
    Spinocerebellar Ataxia Type 32
    Spinocerebellar Ataxia Type 31
    Spinocerebellar Ataxia Type 30
    Spinocerebellar Ataxia Type 3
    Spinocerebellar Ataxia Type 29
    Spinocerebellar Ataxia Type 28
    Spinocerebellar Ataxia Type 27
    Spinocerebellar Ataxia Type 26
    Spinocerebellar Ataxia Type 25
    Spinocerebellar Ataxia Type 23
    Spinocerebellar Ataxia Type 22
    Spinocerebellar Ataxia Type 21
    Spinocerebellar Ataxia Type 20
    Spinocerebellar Ataxia Type 2
    Spinocerebellar Ataxia Type 19/22
    Spinocerebellar Ataxia Type 18
    Spinocerebellar Ataxia Type 17
    Spinocerebellar Ataxia Type 16
    Spinocerebellar Ataxia Type 15/16
    Spinocerebellar Ataxia Type 14
    Spinocerebellar Ataxia Type 13
    Spinocerebellar Ataxia Type 12
    Spinocerebellar Ataxia Type 11
    Spinocerebellar Ataxia Type 10
    Spinocerebellar Ataxia Type 1 With Axonal Neuropathy
    Spinocerebellar Ataxia Type 1
    Spinocerebellar Ataxia - Unknown
    Spinocerebellar Ataxia - Dysmorphism
    Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
    Spasticity-ataxia-gait Anomalies Syndrome
    Spastic Ataxia With Congenital Miosis
    Spastic Ataxia - Corneal Dystrophy
    Spastic Ataxia
    Rare Hereditary Ataxia
    Rare Ataxia
    Recessive Mitochondrial Ataxia Syndrome
    Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
    Posterior Column Ataxia - Retinitis Pigmentosa
    Post-Stroke Ataxia
    Post-Head Injury Ataxia
    Post Vaccination Ataxia
    Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract
    Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus
    Non-hereditary Degenerative Ataxia
    Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity
    Olivopontocerebellar Atrophy - Deafness
    NARP Syndrome
    Myoclonus - Cerebellar Ataxia - Deafness
    Multiple System Atrophy
    Parkinsonian Type
    Multiple System Atrophy
    Cerebellar Type
    Multiple System Atrophy
    Maternally-inherited Leigh Syndrome
    Machado-Joseph Disease Type 3
    Machado-Joseph Disease Type 2
    Machado-Joseph Disease Type 1
    Leigh Syndrome
    Late-onset Ataxia With Dementia
    Infection or Post Infection Ataxia
    GAD Ataxia
    Hereditary Episodic Ataxia
    Gliadin/Gluten Ataxia
    Friedreich Ataxia
    Fragile X-associated Tremor/Ataxia Syndrome
    Familial Paroxysmal Ataxia
    Exposure to Medications Ataxia
    Episodic Ataxia With Slurred Speech
    Episodic Ataxia Unknown Type
    Episodic Ataxia Type 7
    Episodic Ataxia Type 6
    Episodic Ataxia Type 5
    Episodic Ataxia Type 4
    Episodic Ataxia Type 3
    Episodic Ataxia Type 1
    Epilepsy and/or Ataxia With Myoclonus as Major Feature
    Early-onset Spastic Ataxia-neuropathy Syndrome
    Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity
    Early-onset Cerebellar Ataxia With Retained Tendon Reflexes
    Early-onset Ataxia With Dementia
    Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia
    Dilated Cardiomyopathy With Ataxia
    Cataract - Ataxia - Deafness
    Cerebellar Ataxia
    Cayman Type
    Cerebellar Ataxia With Peripheral Neuropathy
    Cerebellar Ataxia - Hypogonadism
    Cerebellar Ataxia - Ectodermal Dysplasia
    Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss
    Brain Tumor Ataxia
    Brachydactyly - Nystagmus - Cerebellar Ataxia
    Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia
    Autosomal Recessive Syndromic Cerebellar Ataxia
    Autosomal Recessive Spastic Ataxia With Leukoencephalopathy
    Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
    Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria
    Autosomal Recessive Spastic Ataxia
    Autosomal Recessive Metabolic Cerebellar Ataxia
    Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine
    Autosomal Recessive Ataxia
    Beauce Type
    Autosomal Recessive Ataxia Due to Ubiquinone Deficiency
    Autosomal Recessive Ataxia Due to PEX10 Deficiency
    Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia
    Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency
    Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency
    Autosomal Recessive Congenital Cerebellar Ataxia
    Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome
    Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency
    Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency
    Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency
    Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome
    Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity
    Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency
    Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect
    Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion
    Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation
    Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness
    Autosomal Recessive Cerebellar Ataxia
    Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly
    Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation
    Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy
    Autosomal Dominant Spastic Ataxia Type 1
    Autosomal Dominant Spastic Ataxia
    Autosomal Dominant Optic Atrophy
    Ataxia-telangiectasia Variant
    Ataxia-telangiectasia
    Autosomal Dominant Cerebellar Ataxia
    Deafness and Narcolepsy
    Autosomal Dominant Cerebellar Ataxia Type 4
    Autosomal Dominant Cerebellar Ataxia Type 3
    Autosomal Dominant Cerebellar Ataxia Type 2
    Autosomal Dominant Cerebellar Ataxia Type 1
    Autosomal Dominant Cerebellar Ataxia
    Ataxia-telangiectasia-like Disorder
    Ataxia With Vitamin E Deficiency
    Ataxia With Dementia
    Ataxia - Oculomotor Apraxia Type 1
    Ataxia - Other
    Ataxia - Genetic Diagnosis - Unknown
    Acquired Ataxia
    Adult-onset Autosomal Recessive Cerebellar Ataxia
    Alcohol Related Ataxia
    Multiple Endocrine Neoplasia
    Multiple Endocrine Neoplasia Type II
    Multiple Endocrine Neoplasia Type 1
    Multiple Endocrine Neoplasia Type 2
    Multiple Endocrine Neoplasia
    Type IV
    Multiple Endocrine Neoplasia
    Type 3
    Multiple Endocrine Neoplasia (MEN) Syndrome
    Multiple Endocrine Neoplasia Type 2B
    Multiple Endocrine Neoplasia Type 2A
    Atypical Hemolytic Uremic Syndrome
    Atypical HUS
    Wiedemann-Steiner Syndrome
    Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)
    Hemophagocytic Lymphohistiocytosis
    Behcet's Disease
    Alagille Syndrome
    Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)
    Lowe Syndrome
    Pitt Hopkins Syndrome
    1p36 Deletion Syndrome
    Jansen Type Metaphyseal Chondrodysplasia
    Cockayne Syndrome
    Chronic Recurrent Multifocal Osteomyelitis
    CRMO
    Malan Syndrome
    Hereditary Sensory and Autonomic Neuropathy Type Ie
    VCP Disease
    Hypnic Jerking
    Sleep Myoclonus
    Mollaret Meningitis
    Recurrent Viral Meningitis
    CRB1
    Leber Congenital Amaurosis
    Retinitis Pigmentosa
    Rare Retinal Disorder
    KCNMA1-Channelopathy
    Primary Biliary Cirrhosis
    ZMYND11
    Transient Global Amnesia
    Glycogen Storage Disease
    Alstrom Syndrome
    White Sutton Syndrome
    DNM1
    EIEE31
    Myhre Syndrome
    Recurrent Respiratory Papillomatosis
    Laryngeal Papillomatosis
    Tracheal Papillomatosis
    Refsum Disease
    Nicolaides Baraitser Syndrome
    Leukodystrophy
    Tango2
    Cauda Equina Syndrome
    Rare Gastrointestinal Disorders
    Achalasia-Addisonian Syndrome
    Achalasia Cardia
    Achalasia Icrocephaly Syndrome
    Anal Fistula
    Congenital Sucrase-Isomaltase Deficiency
    Eosinophilic Gastroenteritis
    Idiopathic Gastroparesis
    Hirschsprung Disease
    Rare Inflammatory Bowel Disease
    Intestinal Pseudo-Obstruction
    Scleroderma
    Short Bowel Syndrome
    Sacral Agenesis
    Sacral Agenesis Syndrome
    Caudal Regression
    Scheuermann Disease
    SMC1A Truncated Mutations (Causing Loss of Gene Function)
    Cystinosis
    Juvenile Nephropathic Cystinosis
    Nephropathic Cystinosis
    Kennedy Disease
    Spinal Bulbar Muscular Atrophy
    Warburg Micro Syndrome
    Mucolipidoses
    Mitochondrial Diseases
    Mitochondrial Aminoacyl-tRNA Synthetases
    Mt-aaRS Disorders
    Hypertrophic Olivary Degeneration
    Non-Ketotic Hyperglycinemia
    Fish Odor Syndrome
    Halitosis
    Isolated Congenital Asplenia
    Lambert Eaton (LEMS)
    Biliary Atresia
    STAG1 Gene Mutation
    Coffin Lowry Syndrome
    Borjeson-Forssman-Lehman Syndrome
    Blau Syndrome
    Arginase 1 Deficiency
    HSPB8 Myopathy
    Beta-Mannosidosis
    TBX4 Syndrome
    DHDDS Gene Mutations
    MAND-MBD5-Associated Neurodevelopmental Disorder
    Constitutional Mismatch Repair Deficiency (CMMRD)
    SPATA5 Disorder
    SPATA5L1 Related Disorder
    Acrodysostosis
    Multi-systematic Smooth Muscle Dysfunction Syndrome
    CRELD1 (Cysteine Rich With EGF Like Domains 1)
    GNB1 Syndrome
    Pyruvate Dehydrogenase Complex Deficiency Disease
    Beta Mannosidosis
    Kbg Syndrome
    Labrune Syndrome
    Metachromatic Leukodystrophy (MLD)
    Moyamoya Disease
    OPHN1 Syndrome
    Oculopharyngeal Muscular Dystrophy (OPMD)
    TUBB3 Mutation
    WOREE (WWOX-related Epileptic Encephalopathy
    SCAR12
    Skraban-Deardorff Syndrome
    Hereditary Myopathy With Early Respiratory Failure

NCT01793168

Sanford Health

7 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.